Encompass Health Corp (EHC) Receives Average Recommendation of “Buy” from Brokerages

Shares of Encompass Health Corp (AMEX:EHC) have earned a consensus recommendation of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation and nine have given a buy recommendation to the company. The average 1 year target price among analysts that have issued ratings on the stock in the last year is $76.38.

EHC has been the subject of several research reports. Zacks Investment Research raised shares of Encompass Health from a “hold” rating to a “buy” rating and set a $69.00 price target for the company in a report on Monday, December 24th. Jefferies Financial Group initiated coverage on shares of Encompass Health in a report on Thursday, December 20th. They issued a “buy” rating for the company.

Encompass Health has a fifty-two week low of $40.86 and a fifty-two week high of $59.29.

Encompass Health (AMEX:EHC) last posted its quarterly earnings results on Thursday, February 7th. The company reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.01. The business had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.09 billion. During the same period last year, the firm posted $0.70 earnings per share. The company’s quarterly revenue was up 8.6% on a year-over-year basis.

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of ∞. The ex-dividend date was Friday, March 29th.

In other news, Director Leo I. Higdon, Jr. bought 1,000 shares of Encompass Health stock in a transaction on Thursday, March 7th. The stock was purchased at an average cost of $58.84 per share, with a total value of $58,840.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.60% of the company’s stock.

A number of institutional investors have recently bought and sold shares of the business. Thrivent Financial for Lutherans boosted its stake in Encompass Health by 5.8% during the 3rd quarter. Thrivent Financial for Lutherans now owns 23,833 shares of the company’s stock valued at $1,858,000 after purchasing an additional 1,317 shares during the period. Koshinski Asset Management Inc. boosted its stake in Encompass Health by 35.0% during the 3rd quarter. Koshinski Asset Management Inc. now owns 5,135 shares of the company’s stock valued at $400,000 after purchasing an additional 1,330 shares during the period. Verition Fund Management LLC boosted its stake in Encompass Health by 12.7% during the 3rd quarter. Verition Fund Management LLC now owns 17,737 shares of the company’s stock valued at $1,383,000 after purchasing an additional 2,003 shares during the period. BlueMountain Capital Management LLC boosted its stake in Encompass Health by 12.7% during the 3rd quarter. BlueMountain Capital Management LLC now owns 22,676 shares of the company’s stock valued at $1,768,000 after purchasing an additional 2,555 shares during the period. Finally, Caxton Associates LP acquired a new position in Encompass Health during the 3rd quarter valued at about $223,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Read More: Growth Stocks

Analyst Recommendations for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.